ALK and non-small cell lung carcinoma: Three to five percent of NSCLC cases harbor anaplastic lymphoma kinase (ALK) gene fusions, the most common of which is echinoderm microtubule-associated protein-like 4-ALK (EML4-ALK) [12,13,14,15,16].